184 related articles for article (PubMed ID: 24694780)
1. Aspirin and other NSAIDs as chemoprevention agents in melanoma.
Goodman JR; Grossman D
Cancer Prev Res (Phila); 2014 Jun; 7(6):557-64. PubMed ID: 24694780
[TBL] [Abstract][Full Text] [Related]
2. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
[TBL] [Abstract][Full Text] [Related]
3. Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial.
Yan MK; Orchard SG; Adler NR; Wolfe R; McLean C; Rodriguez LM; Woods RL; Gibbs P; Chan AT; Haydon A; Mar VJ
Cancer Prev Res (Phila); 2022 Jun; 15(6):365-375. PubMed ID: 35395069
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Disease-Specific Quality of Life and Chemoprevention Utilization in Patients With More Than One Lifetime Skin Cancer.
Gart S; Plampton K; Wysong A; Sutton A
Dermatol Surg; 2024 Feb; 50(2):197-199. PubMed ID: 37962151
[No Abstract] [Full Text] [Related]
5. Aspirin in dermatology: Revisited.
Bubna AK
Indian Dermatol Online J; 2015; 6(6):428-35. PubMed ID: 26753146
[TBL] [Abstract][Full Text] [Related]
6. Aspirin for the primary prevention of skin cancer: A meta-analysis.
Zhu Y; Cheng Y; Luo RC; Li AM
Oncol Lett; 2015 Mar; 9(3):1073-1080. PubMed ID: 25663859
[TBL] [Abstract][Full Text] [Related]
7. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
Nan H; Hutter CM; Lin Y; Jacobs EJ; Ulrich CM; White E; Baron JA; Berndt SI; Brenner H; Butterbach K; Caan BJ; Campbell PT; Carlson CS; Casey G; Chang-Claude J; Chanock SJ; Cotterchio M; Duggan D; Figueiredo JC; Fuchs CS; Giovannucci EL; Gong J; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Jiao S; Lindor NM; Lemire M; Le Marchand L; Newcomb PA; Ogino S; Pflugeisen BM; Potter JD; Qu C; Rosse SA; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Thibodeau SN; Thomas F; Thornquist M; Warnick GS; Zanke BW; Gauderman WJ; Peters U; Hsu L; Chan AT; ;
JAMA; 2015 Mar; 313(11):1133-42. PubMed ID: 25781442
[TBL] [Abstract][Full Text] [Related]
8. Can Aspirin and Cancer Prevention be Ageless Companions?
Farag M
J Clin Diagn Res; 2015 Jan; 9(1):XE01-XE03. PubMed ID: 25738074
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and NSAID chemoprevention, gene-environment interactions, and risk of colorectal cancer.
Wender RC
JAMA; 2015 Mar; 313(11):1111-2. PubMed ID: 25781439
[No Abstract] [Full Text] [Related]
11. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.
Chen CI; Kuan CF; Fang YA; Liu SH; Liu JC; Wu LL; Chang CJ; Yang HC; Hwang J; Miser JS; Wu SY
Medicine (Baltimore); 2015 Feb; 94(6):e462. PubMed ID: 25674734
[TBL] [Abstract][Full Text] [Related]
12. Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance.
Kareva I; Waxman DJ; Lakka Klement G
Cancer Lett; 2015 Mar; 358(2):100-106. PubMed ID: 25541061
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.
Sahu RP; Ocana JA; Harrison KA; Ferracini M; Touloukian CE; Al-Hassani M; Sun L; Loesch M; Murphy RC; Althouse SK; Perkins SM; Speicher PJ; Tyler DS; Konger RL; Travers JB
Cancer Res; 2014 Dec; 74(23):7069-78. PubMed ID: 25304264
[TBL] [Abstract][Full Text] [Related]
15. An update on clinical trials for chemoprevention of human skin cancer.
Jiminez V; Yusuf N
J Cancer Metastasis Treat; 2023; 9(1):. PubMed ID: 37786882
[TBL] [Abstract][Full Text] [Related]
16. Implications of Aspirin for Melanoma Treatment: A Short Perspective.
Thyagarajan A; Sahu RP
J Mol Genet Med (Lond); 2017; 1(1):. PubMed ID: 34927173
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Double-blind Placebo-controlled Trial of Oral Aspirin for Protection of Melanocytic Nevi Against UV-induced DNA Damage.
Okwundu N; Rahman H; Liu T; Florell SR; Boucher KM; Grossman D
Cancer Prev Res (Phila); 2022 Feb; 15(2):129-138. PubMed ID: 34750146
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Effects of Selective COX and LOX Inhibitors and Their Combinations with Antineoplastic Drugs in the Mouse Melanoma Cell Line B16F10.
Da-Costa-Rocha I; Prieto JM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204367
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib.
Tudor DV; Bâldea I; Olteanu DE; Fischer-Fodor E; Piroska V; Lupu M; Călinici T; Decea RM; Filip GA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922284
[TBL] [Abstract][Full Text] [Related]
20. Obesity, Type-2 Diabetes and Cancer: Mechanistic Insights.
Kashfi K; Rosen CL; Aslan M
Crit Rev Oncog; 2019; 24(3):285-305. PubMed ID: 32422026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
